Tudor Investment Corp’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-20,915
| Closed | -$1.94M | – | 2895 |
|
|
2021
Q4 | $1.94M | Buy |
+20,915
| New | +$1.38M | 0.03% | 644 |
|
|
2021
Q3 | – | Sell |
-28,684
| Closed | -$1.96M | – | 2955 |
|
|
2021
Q2 | $1.96M | Buy |
+28,684
| New | +$1.87M | 0.04% | 572 |
|
|
2021
Q1 | – | Sell |
-32,420
| Closed | -$2.49M | – | 1953 |
|
|
2020
Q4 | $2.49M | Buy |
+32,420
| New | +$2.43M | 0.07% | 336 |
|
|
2017
Q2 | – | Sell |
-14,123
| Closed | -$206K | – | 1470 |
|
|
2017
Q1 | $206K | Buy |
14,123
+6,897
| +95% | +$102K | 0.01% | 1210 |
|
|
2016
Q4 | $103K | Buy |
7,226
+4,818
| +200% | +$74.6K | ﹤0.01% | 1306 |
|
|
2016
Q3 | $42K | Sell |
2,408
-212
| -8% | -$3.52K | ﹤0.01% | 1378 |
|
|
2016
Q2 | $45K | Sell |
2,620
-192
| -7% | -$3.43K | ﹤0.01% | 1555 |
|
|
2016
Q1 | $55K | Sell |
2,812
-8,642
| -75% | -$139K | ﹤0.01% | 1649 |
|
|
2015
Q4 | $218K | Buy |
+11,454
| New | +$234K | 0.01% | 1408 |
|
|
2015
Q2 | – | Sell |
-1,581
| Closed | -$69K | – | 1734 |
|
|
2015
Q1 | $69K | Buy |
+1,581
| New | +$73.5K | ﹤0.01% | 1390 |
|
|
2014
Q1 | – | Sell |
-4,513
| Closed | -$264K | – | 1461 |
|
|
2013
Q4 | $264K | Buy |
+4,513
| New | +$236K | 0.01% | 962 |
|
Tudor Investment Corp's ARNA Position: Q1 2022 in Review
Tudor Investment Corp sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 20,915 shares — an estimated $1.94M sold.
Tudor Investment Corp first reported a position in ARNA in Q4 2013 and held it in 11 quarters. The position peaked at $2.49M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Tudor Investment Corp reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Tudor Investment Corp sold 20,915 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.94M.
- Tudor Investment Corp first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 11 quarters.
- Tudor Investment Corp's Arena Pharmaceuticals Inc position peaked at $2.49M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.